418 related articles for article (PubMed ID: 28455234)
21. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
Jahn-Eimermacher A; Hommel G
Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
[TBL] [Abstract][Full Text] [Related]
22. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
Mütze T; Friede T
Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
[TBL] [Abstract][Full Text] [Related]
23. Adaptive designs: The Swiss Army knife among clinical trial designs?
Bretz F; Gallo P; Maurer W
Clin Trials; 2017 Oct; 14(5):417-424. PubMed ID: 28982262
[TBL] [Abstract][Full Text] [Related]
24. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.
Levin GP; Emerson SC; Emerson SS
Stat Med; 2013 Apr; 32(8):1259-75; discussion 1280-2. PubMed ID: 23081665
[TBL] [Abstract][Full Text] [Related]
25. Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.
Emerson SC; Rudser KD; Emerson SS
Stat Med; 2011 May; 30(11):1199-217. PubMed ID: 21538450
[TBL] [Abstract][Full Text] [Related]
26. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
[TBL] [Abstract][Full Text] [Related]
27. Optimization of adaptive designs: efficiency evaluation.
Menon S; Chang M
J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
[TBL] [Abstract][Full Text] [Related]
28. Group sequential, sample size re-estimation and two-stage adaptive designs in clinical trials: a comparison.
Shih WJ
Stat Med; 2006 Mar; 25(6):933-41. PubMed ID: 16220505
[No Abstract] [Full Text] [Related]
29. An objective re-evaluation of adaptive sample size re-estimation: commentary on 'Twenty-five years of confirmatory adaptive designs'.
Mehta C; Liu L
Stat Med; 2016 Feb; 35(3):350-8. PubMed ID: 26757953
[TBL] [Abstract][Full Text] [Related]
30. Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.
Wassmer G
J Biopharm Stat; 2003 Nov; 13(4):585-603. PubMed ID: 14584710
[TBL] [Abstract][Full Text] [Related]
31. Estimation in flexible two stage designs.
Brannath W; König F; Bauer P
Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
[TBL] [Abstract][Full Text] [Related]
32. Blinded sample size re-estimation in crossover bioequivalence trials.
Golkowski D; Friede T; Kieser M
Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
[TBL] [Abstract][Full Text] [Related]
33. Accounting for variation in the required sample size in the design of group-sequential trials.
Grayling MJ; Mander AP
Contemp Clin Trials; 2021 Aug; 107():106459. PubMed ID: 34082076
[TBL] [Abstract][Full Text] [Related]
34. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.
Boessen R; van der Baan F; Groenwold R; Egberts A; Klungel O; Grobbee D; Knol M; Roes K
Pharm Stat; 2013; 12(6):366-74. PubMed ID: 24214896
[TBL] [Abstract][Full Text] [Related]
35. Flexible designs by adaptive plans of generalized Pocock- and O'Brien-Fleming-type and by self-designing clinical trials.
Hartung J
Biom J; 2006 Aug; 48(4):521-36. PubMed ID: 16972703
[TBL] [Abstract][Full Text] [Related]
36. Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints.
Asakura K; Hamasaki T; Evans SR
Biom J; 2017 Jul; 59(4):703-731. PubMed ID: 27757980
[TBL] [Abstract][Full Text] [Related]
37. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
38. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
39. Methods for flexible sample-size design in clinical trials: Likelihood, weighted, dual test, and promising zone approaches.
Shih WJ; Li G; Wang Y
Contemp Clin Trials; 2016 Mar; 47():40-8. PubMed ID: 26674739
[TBL] [Abstract][Full Text] [Related]
40. An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials.
Mi MY; Betensky RA
Clin Trials; 2013 Apr; 10(2):207-15. PubMed ID: 23283576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
